jurgenfr AngioDynamics ( NASDAQ: ANGO ) lost ~14% of value on Thursday, recording its second biggest intraday loss for the year as the medical device maker fell short of Street forecasts with its Q1 revenue for fiscal 2025. The Latham, New York-based firm focused on vascular diseases.
Back to Health Page
